NYSE$CVSA

Covista Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Adtalem's revenue increased, driven by strategic investments and enrollment growth, but earnings decreased due to increased expenses and special items.

Adtalem Global Education reported a 4.8% increase in revenue for the fiscal second quarter 2020, reaching $266.2 million. Diluted earnings per share from continuing operations was $0.10, while diluted earnings per share from continuing operations, excluding special items, was $0.57. The company saw increased enrollments at Chamberlain University and completed the integration of OnCourse Learning.

  • Revenue increased by 4.8% to $266.2 million compared to the prior year.
  • Diluted earnings per share from continuing operations was $0.10, while diluted earnings per share from continuing operations, excluding special items, was $0.57, flat when compared with prior year.
  • Operating income from continuing operations was $40.3 million, while operating income from continuing operations, excluding special items, was $42.3 million, a 9.4% decrease compared with prior year.
  • Net income from continuing operations was $5.5 million, while net income from continuing operations, excluding special items, was $30.9 million, a 9.8% decrease compared with prior year.

Headline financials

Total Revenue

$266M

Previous: $317M-15.9%
EPS (adj)

$0.57

Previous: $0.74-23.0%
Total Students

36.8K

Previous: 36.7K+0.3%
Capital Expenditures

-$20.3M

Previous: -$35.4M+42.6%
Free Cash Flow

-$14.8M

Previous: -$18.1M+18.1%
Net Income

$5.53M

Previous: $17.3M-68.1%
Operating Income

$33.9M

Previous: $101M-66.5%
Gross Profit

$139M

Previous: $158M-12.3%
Cash & Equivalents

$67.3M

Previous: $295M-77.2%
Total Assets

$2.39B

Previous: $2.12B+12.6%
Stock-Based Comp

$3.32M

Previous: $3.22M+3.1%

Revenue & EPS history

Adtalem · Revenue · Quarterly

$266M

Q2 2020-15.9%vs Q2 2019
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

Adtalem · $369M total across 3 segments · Q1 2024

  • Chamberlain
    $143M+5.3%
  • Walden
    $142M+8.2%
  • Medical and Veterinary
    $84.6M-4.1%

Forward guidance

The outlook for the full year 2020 remains unchanged from our guidance issued in the first quarter earnings press release.

Tailwinds

  • Revenue is expected to grow 5% to 7% compared with the prior year
  • Effective income tax rate is expected to be in the 19% to 20% range
  • Earnings per share from continuing operations, excluding special items, are expected to grow in the 7 to 9% range compared with the prior year
  • Full-year capital spending is expected to be in the $45 million to $50 million range

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.7%

Avg return

Earnings day

-0.3%

Avg return

5 days after

+0.7%

Avg return

30 days after

43%

29 / 67 earnings

Positive

+22.8%

Q1 2013

Best reaction

-33.2%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026+13.2%+10.2%+8.0%
Q2 2026-7.8%-14.2%-15.5%
Q1 2026-33.2%-31.2%-34.7%
Q3 2025+16.4%+11.9%+10.7%
Q2 2025+4.6%+7.5%-0.1%
Q1 2025+12.0%+8.7%+23.8%
Q4 2024-7.3%-2.1%-2.2%
Q3 2024+18.9%+24.8%+27.5%
Q2 2024-13.9%-17.5%-15.6%
Q1 2024+12.5%+16.6%+29.4%
Q4 2023-1.1%-4.0%-0.8%
Q3 2023+4.5%+2.0%+2.4%
Q2 2023+13.7%+3.1%+2.2%
Q1 2023+2.4%+6.9%-2.1%
Q4 2022-3.1%-2.6%-2.8%
Q3 2022+6.4%+10.9%+17.5%
Q2 2022-12.7%-16.0%-15.2%
Q1 2022-12.9%-6.0%-16.6%
Q4 2021+1.3%+0.3%+11.8%
Q3 2021-6.9%-8.3%-1.3%
Q2 2021+0.1%+0.9%-2.8%
Q1 2021+3.7%+11.0%+16.6%
Q4 2020-4.4%-6.5%-25.9%
Q3 2020+3.7%+9.8%+11.5%
Q2 2020+3.1%-3.0%-14.9%
Q1 2020-19.2%-16.8%-7.8%
Q4 2019-12.5%-14.6%-20.9%
Q3 2019-7.6%-9.0%-11.4%
Q2 2019-3.3%-3.6%-4.1%
Q1 2019+4.3%+10.7%+14.0%
Q4 2018-15.8%-13.5%-20.0%
Q3 2018-5.7%-3.0%+1.4%
Q2 2018+7.1%+3.7%+12.3%
Q1 2018-2.7%+1.1%+9.7%
Q4 2017+4.3%+4.0%+8.1%
Q3 2017-0.8%+5.0%+0.5%
Q2 2017-0.5%-3.0%+0.2%
Q1 2017+1.8%+1.5%+31.5%
Q4 2016+17.7%+11.8%+4.3%
Q3 2016+17.3%
Q2 2016-14.2%
Q1 2016-2.3%
Q4 2015-7.7%
Q3 2015-15.9%
Q2 2015-17.9%
Q1 2015+0.8%
Q4 2014-3.2%
Q3 2014+13.0%
Q2 2014-2.6%
Q1 2014+6.2%
Q4 2013-9.5%
Q3 2013-17.6%
Q2 2013+19.1%
Q1 2013+22.8%
Q4 2009-2.2%
Q4 2012-2.3%
Q3 2012-0.4%
Q2 2012-8.5%
Q1 2012-0.8%
Q4 2011+4.7%
Q3 2011-1.4%
Q3 2010-1.4%
Q2 2010+0.0%
Q2 2011+0.0%
Q4 2010-1.1%
Q1 2010-1.1%
Q1 2011-1.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro